RARE
Ultragenyx Pharmaceutical Inc. · Healthcare
President and CEO Emil D Kakkis sold $892K of Ultragenyx Pharmaceutical Inc.
Sold$892,352
$45.57Price
19,582Shares
−1%Stake
What RARE did after the filing
- The stock from Wed, Jan 4 open, $45.84
- −3.4%
- S&P 500, same days
- +6.6%
Measured over 30 trading days, to the Feb 16 close.
Traded Fri, Dec 30. Filed Tue, Jan 3, 4:45 PM ET, after the close. Returns use the Jan 4 open and the Feb 16 close. Not investment advice.